0001209191-17-046949.txt : 20170801
0001209191-17-046949.hdr.sgml : 20170801
20170801172611
ACCESSION NUMBER: 0001209191-17-046949
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170731
FILED AS OF DATE: 20170801
DATE AS OF CHANGE: 20170801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PHILLIPS BARCLAY A
CENTRAL INDEX KEY: 0001265801
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 17997654
MAIL ADDRESS:
STREET 1: C/O CANCER VAX CORP
STREET 2: 2110 RUTHERFORD ROAD
CITY: CARLSBAD
STATE: CA
ZIP: 92008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-31
0
0001000694
NOVAVAX INC
NVAX
0001265801
PHILLIPS BARCLAY A
C/O NOVAVAX, INC.
20 FIRSTFIELD ROAD
GAITHERSBURG
MD
20878
0
1
0
0
SVP, Chief Financial Officer
Common Stock
2017-07-31
4
P
0
2057
0.89
A
38669
D
Includes 2,057 shares acquired under the Issuer's Amended and Restated 2013 Employee Stock Purchase Plan on July 31, 2017.
/s/ John A. Herrmann III, Attorney-in-Fact
2017-08-01